IC
CDNA icon

Intel Corp’s CareDx CDNA Stock Holding History

Intel Corp’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4.13M Buy
+590,721
New +$5.68M 10.17% 3

Other funds holding CDNA

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Intel Corp's CDNA Position: Q3 2014 in Review

Intel Corp opened a new position in CareDx (CDNA) in Q3 2014: 590,721 shares worth $4.13M. The stake represents 10.17% of the portfolio and ranks #3 among its holdings.

22 funds tracked by Wall St. Rank hold CDNA as of Q3 2014.

  • Intel Corp held 590,721 shares of CareDx worth $4.13M as of Q3 2014.
  • CareDx was a new Intel Corp position in Q3 2014.
  • CareDx made up 10.17% of Intel Corp's portfolio in Q3 2014, its #3 holding.
  • 22 funds tracked by Wall St. Rank held CareDx as of Q3 2014.

Based on Intel Corp's 13F filing for Q3 2014, filed 12 Nov 2014.